In the present study, we took advantage of a widely established centrifugation-based extracellular vesicle purification strategy and characterized the relationship between HBV and EVs, when the HBV DNA is undetectable in plasma. And, whether the EV-associated HBV is able to transmit infection in naïve hepatoma and immortalized human hepatocyte cell lines.
1A). Institutional Ethics committee approved the study, and patients were enrolled after taking informed written consent.
| Methods
Circulating EVs were isolated from platelet-free plasma using differential ultracentrifugation. The collected EVs were confirmed and characterized using different size latex beads using flow cytometer.
Detailed protocol described previously 7 and in Data S1. However, the presence of other types of vesicles cannot be excluded, and we have therefore referred to the isolated vesicles as extracellular vesicles. 
| RE SULTS
In Group1, HBV DNA was undetected in plasma, but could be detected in EVs in 5 of 9 (60%) (P = 0.00) CHB patients. In Group2, HBV DNA was found in the EVs of all the 12 patients, and its levels were 
| D ISCUSS I ON
We found HBV persists in EVs even when it is undetectable in plasma. EV-associated HBV, though relatively low in quantity was infectious. HBV patients with inactive or fully treated may be carrying F I G U R E 1 A, In Group1, HBV DNA was undetected in plasma but detectable in extracellular vesicles, in 60% of CHB patients. In Group2, HBV DNA is found both in plasma and EVs. The levels of HBV DNA are significantly lower in EVs than plasma. B, The These results suggest that EV-associated HBV is an alternative form for HBV infection and transmission to primary hepatocytes.
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